Загрузка страницы

Optimizing Outcomes Throughout the Journey of Patients With Psoriatic Arthritis

Course Director Philip J. Mease, MD, MACR, discusses psoriatic arthritis management in this CME activity titled "Optimizing Outcomes Throughout the Journey of Patients With Psoriatic Arthritis: A Closer Look at the Importance of Early Diagnosis and Role of New Treatment Options." For the full presentation, downloadable practice aids and slides, complete CME information, and to apply for credit, please visit us at http://www.peerviewpress.com/GVR865. CME credit will be available until July 24, 2018.

Видео Optimizing Outcomes Throughout the Journey of Patients With Psoriatic Arthritis канала PeerView CME
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
16 августа 2017 г. 23:18:25
00:25:20
Другие видео канала
Assessing Recent Advances in Hemophilia A ManagementAssessing Recent Advances in Hemophilia A ManagementDrs. Chodos & Neel discuss #AlzheimersDisease at #IM2023 - https://bit.ly/41gVwsnDrs. Chodos & Neel discuss #AlzheimersDisease at #IM2023 - https://bit.ly/41gVwsnNon–Cystic Fibrosis Bronchiectasis: Leveraging Early Diagnosis and Emerging TherapiesNon–Cystic Fibrosis Bronchiectasis: Leveraging Early Diagnosis and Emerging TherapiesSevere Asthma: Directing New Treatment Approaches at the Airway EpitheliumSevere Asthma: Directing New Treatment Approaches at the Airway EpitheliumEpisode 5. State-of-the-Art Treatment: Catching Up With Current GuidelinesEpisode 5. State-of-the-Art Treatment: Catching Up With Current GuidelinesStrategies for Improving Outcomes in Hypertrophic CardiomyopathyStrategies for Improving Outcomes in Hypertrophic CardiomyopathyEpisode 4: How Can We Talk About VTE to Our Patients?Episode 4: How Can We Talk About VTE to Our Patients?Updating Our Cardio-Oncology Skills in the Cancer Immunotherapy Era: Management of Cardiac irAEsUpdating Our Cardio-Oncology Skills in the Cancer Immunotherapy Era: Management of Cardiac irAEsFcRn Modulation in Myasthenia Gravis: Applying the Evidence, Tools, and Patient PerspectivesFcRn Modulation in Myasthenia Gravis: Applying the Evidence, Tools, and Patient PerspectivesLeveraging the Power of Anti-CD20 mAbs in Patient-Centric Multiple Sclerosis CareLeveraging the Power of Anti-CD20 mAbs in Patient-Centric Multiple Sclerosis CareFacilitating Cognitive Assessment in Primary Care for Timely Detection of Alzheimer’s DiseaseFacilitating Cognitive Assessment in Primary Care for Timely Detection of Alzheimer’s DiseaseTargeted Biologic Therapy for Pediatric and Adult Patients With Moderate to Severe ADTargeted Biologic Therapy for Pediatric and Adult Patients With Moderate to Severe ADImproving the Management of CRS/NP: Selecting the Right Patients for Targeted TreatmentImproving the Management of CRS/NP: Selecting the Right Patients for Targeted TreatmentHBV Is Primary! Your Role in the "Call to Action" to Eliminate Viral Hepatitis By 2030HBV Is Primary! Your Role in the "Call to Action" to Eliminate Viral Hepatitis By 2030Episode 6. Is That Realistic? What We’ve Learned About Anticoagulation Therapy Real-World StudiesEpisode 6. Is That Realistic? What We’ve Learned About Anticoagulation Therapy Real-World StudiesTaking the Pulse of Undiagnosed Atrial FibrillationTaking the Pulse of Undiagnosed Atrial FibrillationAnticipating Treatment Breakthroughs in Rett Syndrome: Steps Toward Timely, Accurate DiagnosisAnticipating Treatment Breakthroughs in Rett Syndrome: Steps Toward Timely, Accurate DiagnosisNew Evidence on Cardiac Myosin Inhibition in Hypertrophic CardiomyopathyNew Evidence on Cardiac Myosin Inhibition in Hypertrophic CardiomyopathyAssessing the Role of Emerging Therapies in the Management of Acid Sphingomyelinase DeficiencyAssessing the Role of Emerging Therapies in the Management of Acid Sphingomyelinase DeficiencyChronic Active Antibody Mediated Rejection  Targeting IL 6 to Improve Outcomes in Kidney TransplantChronic Active Antibody Mediated Rejection Targeting IL 6 to Improve Outcomes in Kidney TransplantExpert Perspectives on Novel Targeted Therapies for Sjögren’s DiseaseExpert Perspectives on Novel Targeted Therapies for Sjögren’s Disease
Яндекс.Метрика